Another interesting fact to note about HCT is that during the last 10 years the number of shares on issue has gone from 130m to 275m ! Compare this figure to other spec companies who go from 200m to 1b share on issue over 2 or 3 years. Over the course of 10 years, while in a R & D phase to achieve such minimal dilution is simply phenomenal, and why its so important for management to hold a large share of the company.
HCT Price at posting:
14.5¢ Sentiment: Buy Disclosure: Held
